标题
Loss of HER2 after HER2-targeted treatment
作者
关键词
Trastuzumab, Breast cancer, HER2
出版物
BREAST CANCER RESEARCH AND TREATMENT
Volume -, Issue -, Pages -
出版商
Springer Nature
发表日期
2019-02-26
DOI
10.1007/s10549-019-05173-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Re-evaluation of HER2 status in patients with HER2-positive advanced or recurrent gastric cancer refractory to trastuzumab (KSCC1604)
- (2018) Hiroshi Saeki et al. EUROPEAN JOURNAL OF CANCER
- Impact of host and histopathological factors on the discrepancies in estrogen receptor, and progesterone receptor, and HER2 status between core needle biopsy and surgically excised tumors
- (2016) Rikiya Nakamura et al. BREAST
- Estrogen, progesterone, and HER2/neu receptor discordance between primary and metastatic breast tumours—a review
- (2016) C. Yeung et al. CANCER AND METASTASIS REVIEWS
- Hormone receptor status does not alter the effect of trastuzumab in breast cancer
- (2016) Tanja Ignatov et al. ENDOCRINE-RELATED CANCER
- Effect of neoadjuvant chemotherapy on breast cancer phenotype, ER/PR and HER2 expression – Implications for the practising oncologist
- (2016) Renu Gahlaut et al. EUROPEAN JOURNAL OF CANCER
- Clinicopathologic Significance of the Intratumoral Heterogeneity of HER2 Gene Amplification in HER2-Positive Breast Cancer Patients Treated With Adjuvant Trastuzumab
- (2015) Hee Jin Lee et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Changes in tumor expression of HER2 and hormone receptors status after neoadjuvant chemotherapy in 21 755 patients from the Japanese breast cancer registry
- (2015) N. Niikura et al. ANNALS OF ONCOLOGY
- Moderate level of HER2 expression and its prognostic significance in breast cancer with intermediate grade
- (2015) Tanja Ignatov et al. BREAST CANCER RESEARCH AND TREATMENT
- Moderate HER2 expression as a prognostic factor in hormone receptor positive breast cancer
- (2015) Holm Eggemann et al. ENDOCRINE-RELATED CANCER
- Loss of HER2 positivity and prognosis after neoadjuvant therapy in HER2-positive breast cancer patients
- (2013) V. Guarneri et al. ANNALS OF ONCOLOGY
- Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
- (2013) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- Loss of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Metastatic Sites of HER2-Overexpressing Primary Breast Tumors
- (2011) Naoki Niikura et al. JOURNAL OF CLINICAL ONCOLOGY
- Loss of HER2 Amplification Following Trastuzumab-Based Neoadjuvant Systemic Therapy and Survival Outcomes
- (2009) E. A. Mittendorf et al. CLINICAL CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now